YORVIPATH 168 ug/.56mL Injection, Solution
Also known as Palopegteriparatide. Coverage in Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota and Wyoming (CMS PDP Region 25).
Not on any stand-alone Part D formulary in Iowa, Minnesota, Montana, Nebraska, North Dakota, South Dakota and Wyoming
None of the 11 stand-alone Part D (PDP) plans in CMS PDP Region 25 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.
3 Medicare Advantage plans in MN, MT do cover it
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. MN: 2 plans · MT: 1 plans.